Frankenius Equity AB

TriSalus Life Sciences, Inc. · 10% Owner

Frankenius Equity AB is listed in public filings as 10 percent owner. This Frankenius Equity AB insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include TriSalus Life Sciences, Inc. (TLSI). Investors use Frankenius Equity AB's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
TriSalus Life Sciences, Inc.TLSI$250k63k sharesBuyDec 17, 2024$3.97--